Twenty pharmaceutical companies created a $1 billion fund to aid financially strained antibiotic development start-ups; the World Health Organization (WHO) concedes that coronavirus disease 2019 (COVID-19) can become airborne; the WHO will launch an independent review into the global pandemic response after the United States formally withdrew from the organization.
Twenty pharmaceutical companies announced the creation of a $1 billion fund to bolster financially strapped biotech start-ups, The New York Times reports. The start-ups are working to develop new antibiotics to combat the increasing number of drug-resistant infections around the globe. The AMR Action Fund will be financed by Roche, Merck, and Johnson & Johnson and was created in partnership with the World Health Organization (WHO). Short-term lifelines will be offered to 2 dozen small antibiotic companies that have been struggling to gain investments. The number of antibiotics approved by the FDA for systemic use has largely decreased, from 61 approved between 1980 and 2009 to only 15 in the last decade.
The WHO recently announced that coronavirus disease 2019 (COVID-19) can become airborne in indoor settings, but some experts felt the acknowledgement should have come sooner, according to The New York Times. The conclusion comes after over 200 scientists signed a letter urging the organization to revise its previous recommendations on the disease and its transmission. In an updated scientific brief, the organization noted the virus may linger in the air in crowded indoor spaces, and it also emphasized that the virus may be spread by asymptomatic individuals.
The WHO will launch an independent review of the international response to the COVID-19 pandemic, STAT News reports. Helen Clarke, former prime minister of New Zealand, and Ellen Johnson Sirleaf, a Nobel Peace Prize winner and former Liberian president, will lead the review while countries can propose potential members for the independent panel. An interim report is expected to be published in November. The announcement comes after President Donald Trump formally notified the WHO that the United States will withdraw from the organization, criticizing its response to the pandemic.
CMS' 340B Repayment Proposal May Harm Vulnerable Hospitals, Reward Those With Higher Revenues
April 26th 2024The 340B hospitals not receiving an offsetting lump-sum payment from CMS following 2018-2022 cuts later ruled unlawful are disproportionately rural, publicly owned, and nonacademic, according to a new study.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Read More